Partners In Health
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1987-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.pih.org
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)
- Conditions
- Hepatitis C, Chronic
- Interventions
- Drug: sofosbubir/velpatasvirDrug: sofosbubir/velpatasvir/voxilaprevir
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Partners in Health
- Target Recruit Count
- 100
- Registration Number
- NCT03888729
- Locations
- 🇷🇼
Rwanda Military Hospital, Kigali, Rwanda
The Pediatric Development Clinic Study
- Conditions
- Pregnancy, Puerperium and Perinatal Conditions
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Partners in Health
- Target Recruit Count
- 376
- Registration Number
- NCT03665012
- Locations
- 🇷🇼
Kirehe District Hospital, Kirehe, Eastern, Rwanda
Expand New Drugs for TB [endTB]
- Conditions
- Tuberculosis, Multidrug-Resistant
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2022-06-13
- Lead Sponsor
- Partners in Health
- Target Recruit Count
- 2804
- Registration Number
- NCT03259269
- Locations
- 🇦🇲
National Treatment Centre for Tuberculosis, Abovian, Armenia, Abovyan, Armenia
🇧🇩National Institute of Diseases of the Chest and Hospital (NIDCH), Dhaka, Dhaka, Bangladesh
🇧🇾Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus
Evaluating the Impact of a Community Health Worker Program in Neno, Malawi
- Conditions
- AsthmaMental Health DisorderMalnutritionDiabetesHIV/AIDSHypertensionAntenatal CareFamily PlanningTuberculosisEpilepsy
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Partners in Health
- Target Recruit Count
- 122395
- Registration Number
- NCT03106727
- Locations
- 🇲🇼
Partners In Health / Abwenzi Pa Za Umoyo, Neno, Malawi
Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Partners in Health
- Target Recruit Count
- 300
- Registration Number
- NCT02964091
- Locations
- 🇷🇼
Rwanda Military Hospital, Kanombe, Kigali, Rwanda
News
Shorter, All-Oral Regimens Show Promise for Rifampin-Resistant Tuberculosis
A phase 3 clinical trial, endTB, has identified three new 9-month, all-oral drug regimens as effective alternatives to the standard 18-24 month treatment for rifampin-resistant tuberculosis.